Researchers say insomnia medicine can treat drug and alcohol addiction
Rutger researchers have identified a biological process for drug and alcohol addiction and believe existing insomnia medicines could be used to reduce cravings.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
Rutger researchers have identified a biological process for drug and alcohol addiction and believe existing insomnia medicines could be used to reduce cravings.
With newer TB drugs to go off patent in 2023, MSF calls on J&J, Otsuka, to lower pricing barriers and allow generic manufacturers.
Sanofi signs $1.2 billion drug discovery deal with AI driven drug startup Insilico
The board of directors of Nitta Gelatin India has approved an INR 1.1 billion expansion plan, according to a BSE filing.
Global vaccine distribution has been inequitable, and vaccines that have been prioritised by the WHO does not see the light of the day,.
Viatris acquires two companies for $750 million to fuel ophthalmology vision
HQ Team November 4, 2022: The management of Cipla, an Indian drug maker, has rejected a plan to transfer its US-based operations based.
HQ Team November 4, 2022: The US-based drugmaker Pfizer Inc and Germany’s BioNTech have started clinical trials for a vaccine to prevent both.
Novo Nordisk net profit rose 14% year-on-year in nine months to September as it forecasted higher profit and sales for the year on.
US suffering drug shortages due to supply chain constraints